Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | NSCLC | Research article

Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues

Authors: Farbod Esfandi, Mohammad Taheri, Mir Davood Omrani, Mohammad Behgam Shadmehr, Shahram Arsang-Jang, Roshanak Shams, Soudeh Ghafouri-Fard

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Non-small cell lung cancer (NSCLC) as the most frequent type of lung cancer is associated with extensive mortality. Researchers have studied the suitability of several molecules as biomarkers for early detection of this cancer. Long non-coding RNAs (lncRNAs) as the main regulators of gene expression have also been assessed in this regard.

Methods

In the present study, we compared expression level of Fas-antisense 1 (FAS-AS1), Growth Arrest Specific 5 (GAS5), PVT1, Nuclear Paraspeckle Assembly Transcript 1 (NEAT1), HOXA transcript antisense RNA myeloid-specific 1 (HOTAIRM1), taurine upregulated gene 1 (TUG1) and TNFα and hnRNPL related immunoregulatory LincRNA (THRIL) in 32 NSCLC samples and their corresponding adjacent non-cancerous tissues (ANCTs).

Results

NEAT1 has been significantly over-expressed in NSCLC tissues obtained from male subjects compared with the corresponding ANCTs (Relative expression (REx) = 3.022, P = 0.019) but not in female subjects (P = 0.975). FAS-AS1 was significantly down-regulated in NSCLC tissues obtained from both males and females subjects compared with the corresponding ANCTs (REx = − 4.12 and − 3.14, P = 0.015 and 0.033 respectively). TUG1, GAS5, THRIL and HOTAIRM1 were significantly down-regulated in tumoral tissues obtained from male subjects compared with the corresponding ANCTs.

Conclusions

The observed dysregulation of these lncRNAs in NSCLC tissues compared with the corresponding ANCTs warrants future studies to confirm the results of the current study in larger sample sizes to elaborate their role as cancer biomarkers.
Literature
1.
go back to reference Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male : female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117(Nov 1):294.CrossRef Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male : female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117(Nov 1):294.CrossRef
2.
go back to reference Morgensztern D, Ng SH, Gao F, Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol. 2010;5:29.CrossRef Morgensztern D, Ng SH, Gao F, Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol. 2010;5:29.CrossRef
3.
go back to reference Wei MM, Zhou GB. Long non-coding RNAs and their roles in non-small-cell lung Cancer. Genom Proteom Bioinf. 2016;14:280.CrossRef Wei MM, Zhou GB. Long non-coding RNAs and their roles in non-small-cell lung Cancer. Genom Proteom Bioinf. 2016;14:280.CrossRef
4.
go back to reference Taheri M, Omrani MD, Ghafouri-Fard S. Long non-coding RNA expression in bladder cancer. Biophys Rev. 2018;10(4):1205–13. Taheri M, Omrani MD, Ghafouri-Fard S. Long non-coding RNA expression in bladder cancer. Biophys Rev. 2018;10(4):1205–13.
5.
go back to reference E. Farbod et al., Expression analysis of OIP5-AS1 in non-small cell lung Cancer. Klin Onkol 31, 260 (Summer, 2018). E. Farbod et al., Expression analysis of OIP5-AS1 in non-small cell lung Cancer. Klin Onkol 31, 260 (Summer, 2018).
6.
go back to reference Xu G, et al. Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis. PLoS One. 2014;9(8):e104044. Xu G, et al. Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis. PLoS One. 2014;9(8):e104044.
7.
go back to reference Yang JC, et al. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer. 2014;85:110.CrossRef Yang JC, et al. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer. 2014;85:110.CrossRef
8.
go back to reference Wei MM, et al. Long non-coding RNA stabilizes the Y-box-binding protein 1 and regulates the epidermal growth factor receptor to promote lung carcinogenesis. Oncotarget. 2016;7:59556.PubMedPubMedCentral Wei MM, et al. Long non-coding RNA stabilizes the Y-box-binding protein 1 and regulates the epidermal growth factor receptor to promote lung carcinogenesis. Oncotarget. 2016;7:59556.PubMedPubMedCentral
9.
go back to reference Wu CH, Hsu CL, Lu PC, Lin WC, Juan HF, Huang HC. Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules. Sci Rep-Uk. 2016;6:35939. Wu CH, Hsu CL, Lu PC, Lin WC, Juan HF, Huang HC. Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules. Sci Rep-Uk. 2016;6:35939.
10.
go back to reference Seiler J, et al. The lncRNA VELUCT strongly regulates viability of lung cancer cells despite its extremely low abundance. Nucleic Acids Res. 2017;45:5458.CrossRef Seiler J, et al. The lncRNA VELUCT strongly regulates viability of lung cancer cells despite its extremely low abundance. Nucleic Acids Res. 2017;45:5458.CrossRef
11.
go back to reference Zhao B, Hou XB, Zhan H. Long non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in non-small cell lung cancer cells. Int J Clin Exp Med. 2015;8:18482.PubMedPubMedCentral Zhao B, Hou XB, Zhan H. Long non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in non-small cell lung cancer cells. Int J Clin Exp Med. 2015;8:18482.PubMedPubMedCentral
12.
go back to reference Zhu LC, Liu JH, Ma SL, Zhang SR. Long noncoding RNA MALAT-1 can predict metastasis and a poor prognosis: a meta-analysis. Pathol Oncol Res. 2015;21:1259.CrossRef Zhu LC, Liu JH, Ma SL, Zhang SR. Long noncoding RNA MALAT-1 can predict metastasis and a poor prognosis: a meta-analysis. Pathol Oncol Res. 2015;21:1259.CrossRef
13.
go back to reference Luo J, et al. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer. Tumor Biol. 2014;35:11541.CrossRef Luo J, et al. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer. Tumor Biol. 2014;35:11541.CrossRef
14.
go back to reference Hu XD, et al. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer. Tumor Biol. 2016;37:3497.CrossRef Hu XD, et al. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer. Tumor Biol. 2016;37:3497.CrossRef
15.
go back to reference Li WH, et al. Genetic variation of lncRNA GAS5 contributes to the development of lung cancer. Oncotarget. 2017;8:91025.PubMedPubMedCentral Li WH, et al. Genetic variation of lncRNA GAS5 contributes to the development of lung cancer. Oncotarget. 2017;8:91025.PubMedPubMedCentral
16.
go back to reference Zhang E, et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis. 2014;5:e1243.CrossRef Zhang E, et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis. 2014;5:e1243.CrossRef
17.
go back to reference Cui D, et al. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer. Tumour Biol. 2016;37:4127.CrossRef Cui D, et al. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer. Tumour Biol. 2016;37:4127.CrossRef
18.
go back to reference Park C, Yu N, Choi I, Kim W, Lee S. lncRNAtor: a comprehensive resource for functional investigation of long non-coding RNAs. Bioinformatics. 2014;30:2480.CrossRef Park C, Yu N, Choi I, Kim W, Lee S. lncRNAtor: a comprehensive resource for functional investigation of long non-coding RNAs. Bioinformatics. 2014;30:2480.CrossRef
19.
go back to reference Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92.CrossRef Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92.CrossRef
20.
go back to reference Warde-Farley D, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214.CrossRef Warde-Farley D, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214.CrossRef
21.
go back to reference Pan LJ, et al. Upregulation and clinicopathological significance of long non-coding NEAT1 RNA in NSCLC tissues. Asian Pac J Cancer Prev. 2015;16:2851.CrossRef Pan LJ, et al. Upregulation and clinicopathological significance of long non-coding NEAT1 RNA in NSCLC tissues. Asian Pac J Cancer Prev. 2015;16:2851.CrossRef
22.
go back to reference Sehgal L, et al. FAS-antisense 1 lncRNA and production of soluble versus membrane FAS in B-cell lymphoma. Leukemia. 2014;28:2376.CrossRef Sehgal L, et al. FAS-antisense 1 lncRNA and production of soluble versus membrane FAS in B-cell lymphoma. Leukemia. 2014;28:2376.CrossRef
23.
go back to reference Kawasaki M, et al. Analysis of Fas and Fas ligand expression and function in lung cancer cell lines. Eur J Cancer (Oxford, England : 1990). 2000;36:656.CrossRef Kawasaki M, et al. Analysis of Fas and Fas ligand expression and function in lung cancer cell lines. Eur J Cancer (Oxford, England : 1990). 2000;36:656.CrossRef
24.
go back to reference Lin PC, Huang HD, Chang CC, Chang YS, Yen JC, Lee CC, Chang WH, Liu TC, Chang JG. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2. BMC Cancer. 2016;16(1):583. Lin PC, Huang HD, Chang CC, Chang YS, Yen JC, Lee CC, Chang WH, Liu TC, Chang JG. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2. BMC Cancer. 2016;16(1):583.
25.
go back to reference Shi XF, et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinogen. 2015;54:E1.CrossRef Shi XF, et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinogen. 2015;54:E1.CrossRef
26.
go back to reference Li Z, et al. The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A. 2014;111:1002.CrossRef Li Z, et al. The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A. 2014;111:1002.CrossRef
27.
go back to reference Tian X, et al. LncRNA HOTAIRM1-HOXA1 axis down-regulates the immunosuppressive activity of myeloid-derived suppressor cells in lung cancer. Front Immunol. 2018;9:473.CrossRef Tian X, et al. LncRNA HOTAIRM1-HOXA1 axis down-regulates the immunosuppressive activity of myeloid-derived suppressor cells in lung cancer. Front Immunol. 2018;9:473.CrossRef
28.
go back to reference Chen X, Xie D, Zhao Q, You ZH. MicroRNAs and complex diseases: from experimental results to computational models. Brief Bioinform. 2017. Chen X, Xie D, Zhao Q, You ZH. MicroRNAs and complex diseases: from experimental results to computational models. Brief Bioinform. 2017.
29.
go back to reference Chen X, Yan CC, Zhang X, You ZH. Long non-coding RNAs and complex diseases: from experimental results to computational models. Brief Bioinform. 2017;18:558.PubMed Chen X, Yan CC, Zhang X, You ZH. Long non-coding RNAs and complex diseases: from experimental results to computational models. Brief Bioinform. 2017;18:558.PubMed
30.
go back to reference Chen X, Yan GY. Novel human lncRNA-disease association inference based on lncRNA expression profiles. Bioinformatics. 2013;29:2617.CrossRef Chen X, Yan GY. Novel human lncRNA-disease association inference based on lncRNA expression profiles. Bioinformatics. 2013;29:2617.CrossRef
31.
go back to reference Chen X, Huang L. LRSSLMDA: Laplacian regularized sparse subspace learning for MiRNA-disease association prediction. PLoS Comput Biol. 2017;13:e1005912.CrossRef Chen X, Huang L. LRSSLMDA: Laplacian regularized sparse subspace learning for MiRNA-disease association prediction. PLoS Comput Biol. 2017;13:e1005912.CrossRef
32.
go back to reference You ZH, et al. PBMDA: a novel and effective path-based computational model for miRNA-disease association prediction. PLoS Comput Biol. 2017;13:e1005455.CrossRef You ZH, et al. PBMDA: a novel and effective path-based computational model for miRNA-disease association prediction. PLoS Comput Biol. 2017;13:e1005455.CrossRef
Metadata
Title
Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues
Authors
Farbod Esfandi
Mohammad Taheri
Mir Davood Omrani
Mohammad Behgam Shadmehr
Shahram Arsang-Jang
Roshanak Shams
Soudeh Ghafouri-Fard
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5435-5

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine